2426-0007: BD Alaris Pump Infusion Set

Sign in to add this product to your favorites!
| Price: | $5.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 266 eaches |
| Expiration: | 12-2026 (or later) |
| Express: | Need it tomorrow? Order in next 3 hours 53 minutes and choose overnight shipping at checkout. |
Additional Details
BD Alaris Pump Infusion Set
Alaris™ Pump Module set Check Valve Roller, Slide Clamp(s) 3 SmartSite™ needle-free valve(s) 6", 74", 90" (1 above pumping segment and 2 below) from 2-piece Male Luer Lock. Not Made with DEHP. 20 Drop L: 126 in L: 320 cm PV: 26 mL Fluid Path Sterile
Product Code: 2426-0007
AccessGUDID Info
- FDA Product Code: FPA
- FDA Product Code Name: Set, administration, intravascular
- GMDN Term Code: 35833
- GMDN Term Name: Electric infusion pump administration set, single-use
- GMDN Term Description: A collection of sterile devices (e.g., plastic tubing, check valve, roller clamp, Y-site connector, Luer, needle/catheter) intended to be used in combination with an electrically-powered infusion pump for the intravenous (IV), subcutaneous, intramuscular, or epidural administration of medication. This is a single-use device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
IN-DATE